Is the second dose of COVID-19 vaccine more harmful than the first dose? Suspension of the second dose of COVID-19 vaccine

The second dose of COVID-19 vaccine has greater side effects than the first dose

COVID-19 vaccine belongs to the first type of vaccine. Many people will have some uncomfortable reactions after vaccination in their daily life, and the same is true after vaccination of COVID-19 vaccine. The specific adverse reactions and degree of adverse reactions will vary from person to person.

The side effects of the second injection of COVID-19 vaccine vary from person to person. Some people feel that the side effects are greater than those of the first injection. Some people also feel that there are no obvious side effects after two injections, so it is still related to the individual's physique. If there are serious side effects, you should go to the hospital in a timely manner, and if they are only mild, they will automatically subside.

Why is the second injection of COVID-19 vaccine painful

If there is a lump or induration at the injection site after the second injection, first observe whether there is swelling or pus. If there is, go to the hospital for surgery, incision, drainage and debridement. If there is only slight pain caused by hardening, you can use sliced raw potatoes to apply to the affected area, which can help reduce inflammation and swelling. It is recommended not to engage in vigorous exercise or lift heavy objects at the affected area.

Why does the second dose of COVID-19 vaccine need to be shot on the right arm.

COVID-19 vaccine is the effect of intramuscular injection through muscle absorption. It has nothing to do with which hand to hit. It's just a shot. The eye needle should not touch water to avoid eye infection. In fact, there is no essential difference between the left arm and the right arm. Don't be too nervous. Usually a round stroke can relieve local pain or discomfort, but the same arm will not affect the effectiveness of the vaccine.

Suspension of the second dose of COVID-19 vaccine

In response to the public's complaints about the difficulty of making an appointment for the second dose, Mi Feng said that when the country allocates and supplies vaccines to provinces, it has fully considered the demand for the second dose of vaccine as scheduled. Each region should make precise adjustments to ensure that the second dose of vaccination is completed within 8 weeks, avoiding situations where the upper dose is administered but not the lower dose. The working groups stationed at various locations of the National Health Commission will also strengthen supervision on this matter.

At present, all regions are actively and orderly promoting the vaccination of COVID-19 vaccine. Cui Gang, the second level inspector of the Disease Control Bureau of the National Health Commission, said: "In the process of implementation, we have repeatedly asked all regions to improve fine management, such as making appointments for vaccination, avoiding people waiting in line for a long time, or avoiding the situation that" we have already made an appointment, but we will not be able to play when we arrive ".

At present, China has five COVID-19 vaccines in use, and the overall COVID-19 Vaccine Research and Development Department has provided vaccine support not only for our country, but also for more than 50 people in other countries. In terms of continuing vaccine research and development, Shao Yiming, a member of the expert group of the vaccine research and development team of the scientific research and development group, introduced that the Chinese government has set up five technical routes in the early stage of the epidemic, among which three technical routes have rushed to the forefront, including three inactivated vaccines and one viral vector vaccine, all of which have been approved by the National Medical Products Administration for conditional marketing and play an important role in current preventive vaccination. Another one is the recombinant protein vaccine, which has also received emergency approval for use.